Battle Over Deferred Drug Listings In Australia: Should Cost-Effective Drugs Always Be Funded?
This article was originally published in The Pink Sheet Daily
Executive Summary
Much to the chagrin of industry, Health Minister Roxon has announced that the Cabinet will now make all decisions about what drugs are listed on the federal drug plan, regardless of price.